Approved share scheme
Certain employees have been granted options over unissued share capital of the company. The options expire ten years after the grant date.
The movements in the number of share options during the year were as follows:
Outstanding at beginning of year: 493,750 (2025: 379,167)
Issued during the year: nil (2025: 114,583)
Lapsed during the year: nil (2025: nil)
Exercised during the year: nil (2025: nil)
Outstanding at end of year: 493,750 (2025: 493,750)
The weighted average exercise price of share options was as follows:
Outstanding at beginning of year: £0.1266 (2025: £0.0001)
Issued during the year: nil (2025: £0.5450)
Exercised during the year: nil (2025: nil)
Outstanding at end of year: £0.1266 (2025: £0.1266)
Unapproved share scheme
Advisors to the company have been granted options over unissued share capital of the company. The options expire ten years after the grant date.
The movements in the number of share options during the year were as follows:
Outstanding at beginning of year: nil (2025: nil)
Issued during the year: 22,076 (2025: nil)
Lapsed during the year: nil (2025: nil)
Exercised during the year: nil (2025: nil)
Outstanding at end of year: 22,076 (2025: nil)
The weighted average exercise price of share options was as follows:
Outstanding at beginning of year: nil (2025: nil)
Issued during the year: £0.0001 (2025: nil)
Exercised during the year: nil (2025: nil)
Outstanding at end of year: £0.0001 (2025: nil)